|8-KFeb 17, 8:33 PM ET

USANA HEALTH SCIENCES INC 8-K

Research Summary

AI-generated summary

Updated

USANA Health Sciences Reports Q4 & FY Results for Period Ended Jan 3, 2026

What Happened

  • USANA Health Sciences, Inc. announced its financial results for the fourth quarter and fiscal year ended January 3, 2026 via a press release issued February 17, 2026. The company also said it will post a “Management Commentary” document on its website and will hold a management-led conference call for investors (broadcast online and by phone) with provided access information. The call will feature brief management remarks followed by a Q&A session.
  • The press release and the Management Commentary are furnished as Exhibits 99.1 and 99.2 to the Form 8‑K and will be posted at www.usana.com. The company noted the information is furnished (not “filed”) under the Securities Exchange Act and is not being incorporated by reference into other registration documents.

Key Details

  • Filing date of the Form 8‑K: February 18, 2026; press release issued February 17, 2026.
  • Reporting period: fourth quarter and fiscal year ended January 3, 2026.
  • Company will post a Management Commentary on its corporate website and host a web/phone investor conference call with prepared remarks then Q&A.
  • Press release and Management Commentary furnished as Exhibits 99.1 and 99.2.

Why It Matters

  • Investors should review the furnished press release and Management Commentary (available on USANA’s website) to see the detailed earnings figures, revenue trends, and management commentary that could affect near‑term stock performance and expectations. The scheduled conference call gives investors an opportunity to hear management’s explanations of results and ask questions. The filing’s “furnished, not filed” status notes the materials are being provided to the market but are not subject to certain legal liabilities tied to filed disclosures.